Medicare Part D coverage · levoketoconazole · RxCUI 2588854
levoketoconazole 150 MG Oral Tablet [Recorlev]
Per the CMS 2026 Part D formulary file, levoketoconazole 150 MG Oral Tablet [Recorlev] is covered by 132 Medicare Part D plans (2.6% of enrollable products), averaging Tier 4.2, with prior authorization required on 87.1% of covering formularies.
- 2.6%
- Plan coverage
- 132
- Plans covering
- T4.2
- Avg tier
- 87.1%
- Prior auth required
What the CMS Formulary Data Shows for levoketoconazole 150 MG Oral Tablet [Recorlev]
Per the CMS 2026 Part D formulary file, levoketoconazole 150 MG Oral Tablet [Recorlev] (RxNorm concept RXCUI 2588854, generic name levoketoconazole) appears on 31 distinct formulary files spanning 132 Medicare Part D plan offerings - 2.6% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 4.2.
Real-world access to levoketoconazole 150 MG Oral Tablet [Recorlev] depends on utilization management as much as tier placement: 87.1% of covering formularies require prior authorization. 0% require step therapy. 38.7% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 85 Part D beneficiaries filled levoketoconazole 150 MG Oral Tablet [Recorlev] in 2023, with total plan-and-beneficiary spending of $9,811,453 and an average per-beneficiary annual cost of $115,428.85. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry levoketoconazole 150 MG Oral Tablet [Recorlev] today.
Coverage Details
- Formularies covering
- 31
- Plans covering
- 132
- Coverage rate
- 2.6%
- Tier range
- Tier 1 – Tier 6
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 87.1% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 38.7% of formularies
2023 Medicare Spending
- Beneficiaries
- 85
- Total spending
- $9,811,453
- Avg per beneficiary
- $115,428.85
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering levoketoconazole 150 MG Oral Tablet [Recorlev]
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| SeniorCare Complete (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| AbilityCare (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| Alameda Alliance Wellness (HMO D-SNP) | Alameda Alliance FOR Health | T1 | Yes | $0 | CA |
| Community Care's Partnership Program (HMO D-SNP) | Community Care Health Plan, Inc. | T1 | No | $0 | WI |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| CareAdvantage (HMO D-SNP) | SAN Mateo Health Commission | T2 | Yes | $0 | CA |
| CalOptima Health OneCare Complete (HMO D-SNP) | Orange County Health Authority | T2 | Yes | $0 | CA |
| Community Blue Medicare HMO Signature (HMO) | Highmark Western and Northeastern New York Inc. | T5 | No | $0 | NY |
| Community Blue Medicare HMO Merit (HMO) | Highmark Western and Northeastern New York Inc. | T5 | No | $0 | NY |
| Community Blue Medicare PPO Signature (PPO) | Highmark Senior Health Company | T5 | No | $0 | PA |
| Complete Blue PPO Signature (PPO) | Highmark Senior Health Company | T5 | No | $0 | PA |
| Community Blue Medicare Plus PPO Signature (PPO) | Highmark Senior Health Company | T5 | No | $0 | PA |
| Complete Blue PPO Signature (PPO) | Highmark Senior Health Company | T5 | No | $0 | PA |
| Complete Blue PPO Merit (PPO) | Highmark Senior Health Company | T5 | No | $0 | PA |
| Complete Blue PPO Signature (PPO) | Highmark Senior Health Company | T5 | No | $0 | PA |
| Complete Blue PPO Distinct (PPO) | Highmark Senior Health Company | T5 | No | $0 | PA |
| Community Blue Medicare Plus PPO Signature (PPO) | Highmark Senior Health Company | T5 | No | $0 | PA |
| Complete Blue Plus PPO Merit (PPO) | Highmark Senior Health Company | T5 | No | $0 | PA |
| Community Blue Medicare PPO Signature (PPO) | Highmark Senior Health Company | T5 | No | $0 | PA |
Show the next 30 plans
| Complete Blue PPO Merit (PPO) | Highmark Senior Health Company | T5 | No | $0 | PA |
| Community Blue Medicare HMO Signature (HMO) | Highmark Choice Company | T5 | No | $0 | PA |
| Security Blue HMO-POS ValueRx (HMO-POS) | Highmark Choice Company | T5 | No | $0 | PA |
| Community Blue Medicare HMO Signature (HMO) | Highmark Choice Company | T5 | No | $0 | PA |
| Together Blue Medicare HMO Signature (HMO) | Highmark Choice Company | T5 | No | $0 | PA |
| Community Blue Medicare HMO Distinct (HMO) | Highmark Choice Company | T5 | No | $0 | PA |
| Complete Blue HMO Distinct (HMO) | Highmark Choice Company | T5 | No | $0 | PA |
| Complete Blue PPO Distinct (PPO) | Highmark Senior Solutions Company | T5 | No | $0 | WV |
| Complete Blue PPO Signature (PPO) | Highmark Senior Solutions Company | T5 | No | $0 | WV |
| Complete Blue PPO Signature (PPO) | Highmark Senior Solutions Company | T5 | No | $0 | WV |
| Complete Blue PPO Merit (PPO) | Highmark Senior Solutions Company | T5 | No | $0 | WV |
| Complete Blue PPO Signature (PPO) | Highmark Bcbsd Inc. | T5 | No | $0 | DE |
| Medicare BlueEssential (PPO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Medicare BlueActive (PPO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Medicare BlueVital (PPO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Univera SeniorChoice Basic (HMO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Univera SeniorChoice Extra (HMO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Medicare Blue Choice Core (HMO) | Excellus Health Plan, Inc. | T5 | Yes | $0 | NY |
| Univera Medicare Dual (HMO D-SNP) | Excellus Health Plan Community Care LLC | T5 | Yes | $0 | NY |
| Medicare Blue Dual (HMO D-SNP) | Excellus Health Plan Community Care LLC | T5 | Yes | $0 | NY |
| Troy Medicare (HMO) | Troy Health, Inc. | T5 | Yes | $0 | NC |
| Troy Medicare for Dual-eligible Beneficiaries (HMO D-SNP) | Troy Health, Inc. | T5 | Yes | $0 | NC |
| Contra Costa Health Care Plus (HMO D-SNP) | Contra Costa County Medical Service DBA Contra Costa Health | T5 | Yes | $0 | CA |
| Keystone First VIP Choice (HMO D-SNP) | Vista Health Plan, Inc. | T5 | Yes | $0 | PA |
| AmeriHealth Caritas VIP Care (HMO D-SNP) | Vista Health Plan, Inc. | T5 | Yes | $0 | PA |
| First Choice VIP Care (HMO D-SNP) | Select Health OF South Carolina, Inc. | T5 | Yes | $0 | SC |
| AmeriHealth Caritas VIP Care (HMO D-SNP) | AmeriHealth Caritas VIP Next, Inc. | T5 | Yes | $0 | DE |
| AmeriHealth Caritas VIP Care Choice (HMO D-SNP) | AmeriHealth Caritas VIP Next, Inc. | T5 | Yes | $0 | DE |
| AmeriHealth Caritas VIP Care (HMO D-SNP) | Amerihealth Caritas Florida, Inc. | T5 | Yes | $0 | FL |
| AmeriHealth Caritas VIP Care (HMO D-SNP) | Amerihealth Caritas Louisiana, Inc. | T5 | Yes | $0 | LA |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is levoketoconazole 150 MG Oral Tablet [Recorlev] covered by Medicare Part D?
Yes, levoketoconazole 150 MG Oral Tablet [Recorlev] is covered by 132 Medicare Part D plans (2.6% of all Part D formularies).
What tier is levoketoconazole 150 MG Oral Tablet [Recorlev] on Medicare Part D plans?
levoketoconazole 150 MG Oral Tablet [Recorlev] averages Tier 4.2 across Part D plans, ranging from Tier 1 to Tier 6.
Does levoketoconazole 150 MG Oral Tablet [Recorlev] require prior authorization?
87.1% of Part D formularies require prior authorization for levoketoconazole 150 MG Oral Tablet [Recorlev]. Step therapy: 0%. Quantity limits: 38.7%.
How much does Medicare spend on levoketoconazole 150 MG Oral Tablet [Recorlev]?
In 2023, total Medicare Part D spending on levoketoconazole 150 MG Oral Tablet [Recorlev] was $9,811,453, covering 85 beneficiaries. The average spend per beneficiary was $115,428.85.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- 24 HR selegiline 0.25 MG/HR Transdermal System [Emsam] T4.2
- lotilaner 2.5 MG/ML Ophthalmic Solution [Xdemvy] T4.2
- glutamine 5000 MG Powder for Oral Solution T4.2
- 1.7 ML denosumab-bbdz 70 MG/ML Injection [Wyost] T4.2
- {4 (apremilast 10 MG Oral Tablet [Otezla]) / 51 (apremilast 20 MG Oral Tablet [Otezla]) } Pack [Otezla 28-Day 10/20 Starter Pack] T4.2
- apremilast 20 MG Oral Tablet [Otezla] T4.2
Similar prior-authorization rate
- trientine hydrochloride 250 MG Oral Capsule 87.1% PA
- thalidomide 50 MG Oral Capsule [Thalomid] 87.2% PA
- 1.7 ML denosumab-bmwo 70 MG/ML Injection [Osenvelt] 87.3% PA
- 1.5 ML leuprolide acetate 30 MG/ML Prefilled Syringe [Lupron] 86.8% PA
- crinecerfont 50 MG/ML Oral Solution [Crenessity] 86.7% PA
- Once-Daily gabapentin 300 MG Oral Tablet 87.5% PA